MetLife Investment Management, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1529735
Whippany, NJ
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,387,383
+$1,035,769 QoQ
Shares Held
35,792
+12.6% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#108
of 343 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. PTGX ranks #18 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in PTGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,387,383 | 35,792 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,351,614 | 31,799 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,833,309 | 32,440 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,248,389 | 33,846 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,921,737 | 34,770 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,682,444 | 34,790 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,381,802 | 35,798 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,521,225 | 33,805 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,171,343 | 33,805 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $827,282 | 28,596 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $655,706 | 28,596 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $476,981 | 28,596 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $789,821 | 28,596 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $550,022 | 23,914 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $260,901 | 23,914 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $201,595 | 23,914 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $189,159 | 23,914 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $566,283 | 23,914 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $516,009 | 15,088 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $267,359 | 15,088 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $677,149 | 15,088 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $350,271 | 13,524 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $272,643 | 13,524 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $264,394 | 13,524 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $190,657 | 10,796 | Shares | Defined | 2024-05-24 | |
| No filing history on record for this holder in this stock. | ||||||